Glanzmann Thrombasthenia, Autosomal Dominant
|
0.900 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Demonstration of novel gain-of-function mutations of αIIbβ3: association with macrothrombocytopenia and glanzmann thrombasthenia-like phenotype.
|
24498605 |
2013 |
Glanzmann Thrombasthenia, Autosomal Dominant
|
0.900 |
GeneticVariation
|
disease |
UNIPROT |
Heterozygous ITGA2B R995W mutation inducing constitutive activation of the αIIbβ3 receptor affects proplatelet formation and causes congenital macrothrombocytopenia.
|
21454453 |
2011 |
Glanzmann Thrombasthenia, Autosomal Dominant
|
0.900 |
Biomarker
|
disease |
MGD |
Thrombasthenic mice generated by replacement of the integrin alpha(IIb) gene: demonstration that transcriptional activation of this megakaryocytic locus precedes lineage commitment.
|
10942384 |
2000 |
Glanzmann Thrombasthenia, Autosomal Dominant
|
0.900 |
GeneticVariation
|
disease |
UNIPROT |
R to Q amino acid substitution in the GFFKR sequence of the cytoplasmic domain of the integrin IIb subunit in a patient with a Glanzmann's thrombasthenia-like syndrome.
|
9834222 |
1998 |
Glanzmann Thrombasthenia, Autosomal Dominant
|
0.900 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
R to Q amino acid substitution in the GFFKR sequence of the cytoplasmic domain of the integrin IIb subunit in a patient with a Glanzmann's thrombasthenia-like syndrome.
|
9834222 |
1998 |
Glanzmann Thrombasthenia, Autosomal Dominant
|
0.900 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Glanzmann Thrombasthenia, Autosomal Dominant
|
0.900 |
Biomarker
|
disease |
CTD_human |
|
|
|
Thrombasthenia
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
We analyzed the expression of GPIIb/IIIa and the gene sequencing in two pedigrees with GT, so as to determine the type and the relationship between genotype and clinical phenotype.
|
31088191 |
2020 |
Thrombasthenia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
In silico analysis of structural modifications in and around the integrin αIIb genu caused by ITGA2B variants in human platelets with emphasis on Glanzmann thrombasthenia.
|
29385657 |
2018 |
Thrombasthenia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
We diagnosed a pathogenic Glanzmann thrombasthenia mutation in ITGA2B screened by DHPLC that appears to be specific to individuals of Tunisian heritage and that deserves to be investigated in first intention.
|
30325339 |
2018 |
Thrombasthenia
|
0.800 |
Biomarker
|
disease |
BEFREE |
As expected, MC and FFC revealed that GT platelets had significantly reduced CD41, CD61, and activated integrin αIIbβ3 surface expression.
|
29985398 |
2018 |
Thrombasthenia
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
Type I GT was found most common in our patients and with lowered mean CD41 expression in comparison with CD61.
|
28948953 |
2017 |
Thrombasthenia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
This study reported three novel mutations expanding the genotypic spectrum of ITGA2B causing GT.
|
28888044 |
2017 |
Thrombasthenia
|
0.800 |
Biomarker
|
disease |
BEFREE |
: Quantitative and/or qualitative defects of the platelet membrane glycoprotein IIb/IIIa complex lead to the clinical entity of Glanzmann's thrombasthenia.
|
29084015 |
2017 |
Thrombasthenia
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
Forty children with GT were assessed for the expression of GPIIb-IIIa on the platelet surface and platelet antibodies by using flow cytometry, to determine the most common GT subtypes among Egyptian children.
|
28161816 |
2017 |
Thrombasthenia
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
Moreover, exogenous expression of the wild-type ITGA2B gene in GT-iPS platelets restored CD41 expression and normal platelet aggregation.
|
28232155 |
2017 |
Thrombasthenia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
A series of haplogroups, often including HPA-3b in ITGA2B, repeated with little variation across unrelated families of wide geographical origins and with different GT-causing mutations whether in ITGA2B or ITGB3.
|
27469266 |
2016 |
Thrombasthenia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Expanding the Mutation Spectrum Affecting αIIbβ3 Integrin in Glanzmann Thrombasthenia: Screening of the ITGA2B and ITGB3 Genes in a Large International Cohort.
|
25728920 |
2015 |
Thrombasthenia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Homozygous or compound heterozygous mutations in ITGA2B or ITGB3 were identified as causing GT by sequencing of genomic DNA.
|
25373348 |
2015 |
Thrombasthenia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Novel mutations of integrin αIIb and β3 genes in Turkish children with Glanzmann's thrombasthenia.
|
25734216 |
2015 |
Thrombasthenia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
We now report a Catalan family where type I GT is given by compound heterozygosity within ITGA2B with a Gly13Val substitution in αIIb associated with a 13 bp deletion involving the splice site of exon 15.
|
22394243 |
2013 |
Thrombasthenia
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
One patient, who showed Glanzmann thrombasthenia-like marked reduction in surface αIIbβ3 expression (3-11% of normal control), was a compound heterozygote with ITGA2B p.Gly991Cys and a novel nonsense mutation, ITGA2B p.Arg422*.
|
24498605 |
2013 |
Thrombasthenia
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Novel and recurrent mutations of ITGA2B and ITGB3 genes in Korean patients with Glanzmann thrombasthenia.
|
22190468 |
2012 |
Thrombasthenia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Antibody screening was performed on a large series of 24 GT patients in South-West France dividing the patients into two cohorts: (i) 16 patients with the French gypsy mutation (c.1544 + 1G>A) within ITGA2B that gives platelets totally lacking αIIbβ3 and (ii) 8 patients carrying other defects of ITGA2B or ITGB3 with different expression levels of αIIbβ3.
|
22250950 |
2012 |
Thrombasthenia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Novel and recurrent mutations of ITGA2B and ITGB3 genes in Korean patients with Glanzmann thrombasthenia.
|
22190468 |
2012 |